person

Nika G.

Country
Germany
Department
Strahlentherapie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 24 partner sites.

Specializations

Metastatic Renal Cell Carcinoma & Kidney‑Related Oncology

The investigator applies precision radiation oncology to improve local control and symptom relief in advanced kidney cancers.

  • Advanced or Metastatic Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Non‑clear cell Renal Cell Carcinoma
  • Kidney transplant‑related malignancies

Therapeutic strategies emphasize stereotactic body radiotherapy and combined modality approaches.

Thoracic Malignancies Including NSCLC

Focused on delivering curative and palliative irradiation for a spectrum of lung and mediastinal cancers.

  • Advanced Non‑Small Cell Lung Cancer
  • ALK‑positive NSCLC
  • KRAS‑mutated NSCLC
  • Small Cell Lung Cancer
  • Mesothelioma

Integration of image‑guided techniques supports dose escalation while protecting thoracic organs.

Central Nervous System Tumors & Brain Metastases

Specializes in high‑precision cranial irradiation for primary and secondary brain lesions.

  • Glioblastoma
  • Brain metastases from solid tumors
  • Primary CNS lymphoma
  • Medulloblastoma
  • Ependymoma

Techniques include stereotactic radiosurgery and hippocampal‑sparing whole‑brain radiotherapy.

Radiation in Hematologic Malignancies

Applies targeted radiotherapy to manage disease burden and prevent relapse in blood cancers.

  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Diffuse Large B‑Cell Lymphoma
  • Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia

Approaches include total marrow irradiation and involved‑site radiotherapy.

Molecularly Defined Rare Tumors

Targets rare cancers driven by specific genetic alterations with tailored radiation protocols.

  • KRAS G12C‑mutated solid tumors
  • ALK‑positive anaplastic large‑cell lymphoma
  • BRAF‑mutant melanoma
  • RET‑mutant medullary thyroid cancer
  • HER2‑positive gastric carcinoma

Radiation planning incorporates biomarker status to optimize therapeutic windows.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.